---
figid: PMC9262551__OMCL2022-9687925.003
figtitle: Relevance of NLRP3 Inflammasome-Related Pathways in the Pathology of Diabetic
  Wound Healing and Possible Therapeutic Targets
organisms:
- Bletilla striata
- Homo sapiens
pmcid: PMC9262551
filename: OMCL2022-9687925.003.jpg
figlink: /pmc/articles/PMC9262551/figure/fig3/
number: F3
caption: 'Therapeutic targeting of NLRP3 inflammasome in DW. Activation of Nrf2-mediated
  antioxidant defenses and suppression of NF-κB/NLRP3 inflammasome-mediated anti-inflammatory
  action are effective therapeutic strategies, which also include GC-AgNPs-CGP, plumbagin,
  neferine, rutin, and luteolin. Metformin and rapamycin target AMPK and mTOR to inhibit
  the NF-κB signaling pathway, consequently blocking the priming of the NLRP3 inflammasome.
  Glyburide suppresses NLRP3 oligomerization in an ATPase-dependent manner. P2X7 is
  a vital target of BBG, Zol, and MFG-E8. In addition, inhibition of TXNIP by fenofibrate
  can regulate the ROS-mediated NLRP3 inflammasome to exert a beneficial effect on
  DW. NAC and SKQ1 inhibit ROS and mROS, respectively, to block the assembly of the
  NLRP3 inflammasome. YVAD is a specific inhibitor of caspase-1. Additionally, BAY
  11-7082, BSP, and melatonin directly black the oligomerization of NLRP3 to exert
  beneficial effect for DW healing. Abbreviation: DW: diabetic wound; NLRP3: Nod-like
  receptor protein; ROS: reactive oxygen species; TXNIP: thioredoxin-interacting protein;
  Nrf2: nuclear factor erythroid-2-related factor; GC-AgNPs-CGP: gallocatechin-silver
  nanoparticle-impregnated cotton gauze patches; AMPK: AMP-activated protein kinase;
  mTOR: mammalian target of rapamycin; BBG: brilliant blue G; Zol: zoledronate; MFG-E8:
  milk fat globule epidermal growth factor VIII; NAC: N-acetylcysteine; mROS: mitochondrial
  reactive oxygen species; BSP: Bletilla striata polysaccharide; SKQ1: 10-(6′-plastoquinonyl)
  decyltriphenylphosphonium; YVAD: Tyr-Val-Ala-Asp.'
papertitle: Relevance of NLRP3 Inflammasome-Related Pathways in the Pathology of Diabetic
  Wound Healing and Possible Therapeutic Targets.
reftext: Youjun Ding, et al. Oxid Med Cell Longev. 2022;2022:9687925.
year: '2022'
doi: 10.1155/2022/9687925
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.9549136
figid_alias: PMC9262551__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9262551__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9262551__OMCL2022-9687925.003.html
  '@type': Dataset
  description: 'Therapeutic targeting of NLRP3 inflammasome in DW. Activation of Nrf2-mediated
    antioxidant defenses and suppression of NF-κB/NLRP3 inflammasome-mediated anti-inflammatory
    action are effective therapeutic strategies, which also include GC-AgNPs-CGP,
    plumbagin, neferine, rutin, and luteolin. Metformin and rapamycin target AMPK
    and mTOR to inhibit the NF-κB signaling pathway, consequently blocking the priming
    of the NLRP3 inflammasome. Glyburide suppresses NLRP3 oligomerization in an ATPase-dependent
    manner. P2X7 is a vital target of BBG, Zol, and MFG-E8. In addition, inhibition
    of TXNIP by fenofibrate can regulate the ROS-mediated NLRP3 inflammasome to exert
    a beneficial effect on DW. NAC and SKQ1 inhibit ROS and mROS, respectively, to
    block the assembly of the NLRP3 inflammasome. YVAD is a specific inhibitor of
    caspase-1. Additionally, BAY 11-7082, BSP, and melatonin directly black the oligomerization
    of NLRP3 to exert beneficial effect for DW healing. Abbreviation: DW: diabetic
    wound; NLRP3: Nod-like receptor protein; ROS: reactive oxygen species; TXNIP:
    thioredoxin-interacting protein; Nrf2: nuclear factor erythroid-2-related factor;
    GC-AgNPs-CGP: gallocatechin-silver nanoparticle-impregnated cotton gauze patches;
    AMPK: AMP-activated protein kinase; mTOR: mammalian target of rapamycin; BBG:
    brilliant blue G; Zol: zoledronate; MFG-E8: milk fat globule epidermal growth
    factor VIII; NAC: N-acetylcysteine; mROS: mitochondrial reactive oxygen species;
    BSP: Bletilla striata polysaccharide; SKQ1: 10-(6′-plastoquinonyl) decyltriphenylphosphonium;
    YVAD: Tyr-Val-Ala-Asp.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GABPA
  - NFE2L2
  - MTOR
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - REL
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - IRF6
  - NFKB1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - TJP1
  - MFGE8
  - P2RX7
  - ATP8A2
  - NLRP3
  - IBSP
  - TXNIP
  - STS
  - PYCARD
  - XK
  - NLRP1
---
